PatientsVille.com Logo

Aspegic Side Effects

PatientsVille

Common Aspegic Side Effects


The most commonly reported Aspegic side effects (click to view or check a box to report):

Alanine Aminotransferase Increased (4)
Toxic Epidermal Necrolysis (4)
Thrombocytopenia (4)
Aspartate Aminotransferase Increased (4)
Coma (3)
Gamma-glutamyltransferase Increased (3)
Pruritus (3)
Renal Failure Acute (3)
Rash (3)
Glomerulonephropathy (2)
Abdominal Pain (2)
Blood Alkaline Phosphatase Increased (2)
Loss Of Consciousness (2)
Aphasia (2)
Subarachnoid Haemorrhage (2)
Somnolence (2)
Skin Test Negative (2)
Pyrexia (2)
Purpura (2)
Prothrombin Level Decreased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Aspegic Side Effects Reported to FDA



Aspegic Side Effect Report#9361639
Confusional State, Hallucination
This is a report of a 88-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: prophylaxis,hypersensitivity, who was treated with Aspegic (dosage: NA, start time: NS), combined with:
  • Telfast
  • Plavix
  • Lamaline
  • Lyrica
  • Travatan
  • Trusopt
  • Fluoxetine
  • Ventoline
and developed a serious reaction and side effect(s): Confusional State, Hallucination after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic treatment in female patients, resulting in Confusional State side effect. The patient was hospitalized.
Aspegic Side Effect Report#9213612
Hepatocellular Injury, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Rash
This report suggests a potential Aspegic Hepatocellular Injury side effect(s) that can have serious consequences. A 77-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Aspegic (dosage: NA) starting
Jan 30, 2013. After starting Aspegic the patient began experiencing various side effects, including: Hepatocellular Injury, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, RashAdditional drugs used concurrently:
  • Plavix
  • Lovenox
  • Lasilix
  • Tahor (Strength: 80 Mg)
  • Umuline
  • Loxen (Strength: 10 Mg/10 Ml)
  • Eupantol
  • Phloroglucinol
The patient was hospitalized. Although Aspegic demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hepatocellular Injury, may still occur.
Aspegic Side Effect Report#8978161
Anaemia
This Anaemia problem was reported by a health professional from FR. A 84-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Aspegic (dosage: NA). The following drugs were being taken at the same time:
  • Plavix
  • Amiodarone
When using Aspegic, the patient experienced the following unwanted symptoms/side effects: AnaemiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Anaemia, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#8395347-0
Splenic Haemorrhage
This Splenic Haemorrhage side effect was reported by a health professional from France. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: cerebrovascular accident.The patient was prescribed Aspegic 1000 (drug dosage: 1 Df, 1x/day), which was initiated on
May 04, 2012. Concurrently used drugs:
  • Orgaran (1 Df, 2x/day)
  • Argatroban (2.4 Ml/hr)
.After starting to take Aspegic 1000 the consumer reported adverse symptoms, such as: Splenic HaemorrhageThese side effects may potentially be related to Aspegic 1000.
Aspegic Side Effect Report#8395213-0
Altered State Of Consciousness, Encephalopathy
This is a report of a male patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Aspegic 1000 (dosage: NA, start time:
Nov 21, 2011), combined with:
  • Pegasys (Dosage Form: Solution For Injection, On Each Mondays)
  • Acetaminophen (One Hour Before Pegasys* Injection)
  • Incivo (telaprevir) (Dosage Form: Tablet)
  • Copegus (200 Mg : 2-0-3)
  • Atorvastatin
and developed a serious reaction and side effect(s): Altered State Of Consciousness, Encephalopathy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 1000 treatment in male patients, resulting in Altered State Of Consciousness side effect. The patient was hospitalized.
Aspegic Side Effect Report#8394573-4
Pyelonephritis, Infection
This report suggests a potential Aspegic 1000 Pyelonephritis side effect(s) that can have serious consequences. A 72-year-old female patient (weight: NA) from Tunisia was diagnosed with the following symptoms/conditions: NA and used Aspegic 1000 (dosage: NA) starting
Jul 10, 2011. After starting Aspegic 1000 the patient began experiencing various side effects, including: Pyelonephritis, InfectionAdditional drugs used concurrently:
  • Insulatard Nph Human
  • Plavix
  • Atorvastatin Calcium
  • Ramipril
  • Lasix
Although Aspegic 1000 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pyelonephritis, may still occur.
Aspegic Side Effect Report#8363429-5
Thrombophlebitis Superficial
This Thrombophlebitis Superficial problem was reported by a health professional from France. A 65-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Apr 11, 2012 this consumer started treatment with Aspegic 1000 (dosage: 250 Mg (500 Mg/5 Ml), Daily). The following drugs were being taken at the same time:
  • Nicotine
  • Novomix
  • Pantoprazole (40 Mg, Daily)
  • Insulin (Unk)
  • Lovenox (40 Mg, Unk)
  • Lexomil
  • Atorvastatin (40 Mg, Daily)
  • Sodium Chloride (1000 Mg, Unk)
When using Aspegic 1000, the patient experienced the following unwanted symptoms/side effects: Thrombophlebitis SuperficialThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thrombophlebitis Superficial, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#8327939-9
Cerebral Haematoma
This Brain Death side effect was reported by a health professional from France. A 77-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Aspegic 1000 (drug dosage: NA), which was initiated on
Apr 06, 2012. Concurrently used drugs:
  • Budesonide/formoterol Fumarate (Strength; 400/12 Mcg, Form; Powder For Inhalation)
  • Heparin Sodium
  • Aspirin
  • Lercanidipine (Strength; 20 Mg)
  • Orbenin Cap
  • Spiriva (Strength; 18 Mcg)
  • Amoxicillin
  • Plavix
.After starting to take Aspegic 1000 the consumer reported adverse symptoms, such as: Cerebral HaematomaThese side effects may potentially be related to Aspegic 1000. The patient was hospitalized.
Aspegic Side Effect Report#8141943-5
Subarachnoid Haemorrhage, Coma
This is a report of a 68-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: acute coronary syndrome, who was treated with Aspegic 325 (dosage: 250mg Per Day, start time:
Nov 01, 2011), combined with:
  • Arixtra (2.5mg Per Day)
and developed a serious reaction and side effect(s): Subarachnoid Haemorrhage, Coma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in female patients, resulting in Subarachnoid Haemorrhage side effect.
Aspegic Side Effect Report#8127641-2
Hypoglycaemia, Maternal Exposure During Pregnancy
This report suggests a potential Aspegic 1000 Hypoglycaemia side effect(s) that can have serious consequences. A 31-year-old female patient (weight: NA) from Algeria was diagnosed with the following symptoms/conditions: platelet aggregation inhibition and used Aspegic 1000 (dosage: 100 Mg, Qd (before Pregnancy Starts)) starting NS. After starting Aspegic 1000 the patient began experiencing various side effects, including: Hypoglycaemia, Maternal Exposure During PregnancyAdditional drugs used concurrently:
  • Daflon /00426001/ (2 Tab, Qd (during 2nd Trimester Of Pregnancy))
  • Novorapid Flexpen (3 Injections Of 06 Iu)
  • Insulatard Penfill (1 Injection Of 06 Ui)
Although Aspegic 1000 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hypoglycaemia, may still occur.
Aspegic Side Effect Report#8072856-5
Thrombocytopenia, Renal Failure Acute
This Thrombocytopenia problem was reported by a health professional from France. A 90-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 22, 2011 this consumer started treatment with Aspegic 325 (dosage: Unk). The following drugs were being taken at the same time:
  • Acetaminophen (Unk)
  • Ofloxacin (400 Mg, Daily)
  • Ceftriaxone Sodium (1 G, Unk)
  • Lasix (Unk)
  • Pantoprazole (20 Mg, Daily)
  • Enoxaparin Sodium (1 Df, Unk)
  • Arimidex
  • Deroxat (Unk)
When using Aspegic 325, the patient experienced the following unwanted symptoms/side effects: Thrombocytopenia, Renal Failure AcuteAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thrombocytopenia, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#8064015-7
Skin Test Negative, Toxic Epidermal Necrolysis
This Skin Test Negative side effect was reported by a health professional from France. A 9-year-old female patient (weight:NA) experienced the following symptoms/conditions: pyrexia.The patient was prescribed Aspegic 325 (drug dosage: 1 Df, Single), which was initiated on
Oct 30, 2010. Concurrently used drugs:
  • Acetaminophen (1 Df, Single)
  • Ibuprofen (advil) (1 Df, Single)
.After starting to take Aspegic 325 the consumer reported adverse symptoms, such as: Skin Test Negative, Toxic Epidermal NecrolysisThese side effects may potentially be related to Aspegic 325. The patient was hospitalized.
Aspegic Side Effect Report#8060447-1
Subarachnoid Haemorrhage, Coma
This is a report of a 68-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: acute coronary syndrome, who was treated with Aspegic 325 (dosage: 250mg Per Day, start time:
Nov 01, 2011), combined with:
  • Arixtra (2.5mg Per Day)
and developed a serious reaction and side effect(s): Subarachnoid Haemorrhage, Coma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in female patients, resulting in Subarachnoid Haemorrhage side effect.
Aspegic Side Effect Report#8045649-2
Skin Test Negative, Toxic Epidermal Necrolysis
This report suggests a potential Aspegic 325 Skin Test Negative side effect(s) that can have serious consequences. A 9-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: pyrexia and used Aspegic 325 (dosage: 1 Df, Single) starting
Oct 30, 2010. After starting Aspegic 325 the patient began experiencing various side effects, including: Skin Test Negative, Toxic Epidermal NecrolysisAdditional drugs used concurrently:
  • Acetaminophen (1 Df, Single)
  • Ibuprofen (advil) (1 Df, Single)
The patient was hospitalized. Although Aspegic 325 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Skin Test Negative, may still occur.
Aspegic Side Effect Report#8025373-2
Rash Papular, Pruritus
This Rash Papular problem was reported by a health professional from France. A 50-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Oct 19, 2011 this consumer started treatment with Aspegic 325 (dosage: 100 Mg, 1x/day). The following drugs were being taken at the same time:
  • Perindopril Erbumine (1 Mg, 1x/day)
  • Sectral (Unk)
  • Atorvastatin Calcium (80 Mg, 1x/day)
  • Plavix (75 Mg, 1x/day)
  • Plavix (75 Mg, 2x/week)
When using Aspegic 325, the patient experienced the following unwanted symptoms/side effects: Rash Papular, PruritusThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Rash Papular, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#8015458-9
Dry Skin, Psoriasis
This Dry Skin side effect was reported by a physician from France. A male patient (weight:NA) experienced the following symptoms/conditions: platelet aggregation inhibition,prophylaxis against transplant rejection.The patient was prescribed Aspegic 325 (drug dosage: NA), which was initiated on
Dec 01, 2005. Concurrently used drugs:
  • Prograf
  • Mycophenolate Mofetil (cellcept)
  • Pantoprazole Sodium
  • Tacrolimus (2 Mg, Uid/qd)
  • Lamivudine
  • Prazosin Hcl
  • Prazepam
.After starting to take Aspegic 325 the consumer reported adverse symptoms, such as: Dry Skin, PsoriasisThese side effects may potentially be related to Aspegic 325.
Aspegic Side Effect Report#8013600-7
Renal Failure Acute
This is a report of a 77-year-old male patient (weight: NA) from Tunisia, suffering from the following health symptoms/conditions: NA, who was treated with Aspegic 325 (dosage: NA, start time:
Oct 20, 2011), combined with:
  • Plavix
  • Atorvastatin
  • Insulin
  • Plavix
and developed a serious reaction and side effect(s): Renal Failure Acute after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in male patients, resulting in Renal Failure Acute side effect.
Aspegic Side Effect Report#7968902-7
Coagulation Factor V Level Decreased, Alanine Aminotransferase Increased, Neutrophil Count Increased, White Blood Cell Count Increased, Gamma-glutamyltransferase Increased, Blood Creatine Phosphokinase Increased, Prothrombin Time Prolonged, Activated Partial Thromboplastin Time Prolonged, Aspartate Aminotransferase Increased
This report suggests a potential Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) Coagulation Factor V Level Decreased side effect(s) that can have serious consequences. A 81-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) (dosage: NA) starting
May 01, 2011. After starting Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) the patient began experiencing various side effects, including: Coagulation Factor V Level Decreased, Alanine Aminotransferase Increased, Neutrophil Count Increased, White Blood Cell Count Increased, Gamma-glutamyltransferase Increased, Blood Creatine Phosphokinase Increased, Prothrombin Time Prolonged, Activated Partial Thromboplastin Time Prolonged, Aspartate Aminotransferase IncreasedAdditional drugs used concurrently:
  • Kardegic (acetylsalicylic Lysine, Acetylsalicylic Acid)
  • Mupiderm (mupirocin)
  • Spironolactone
  • Nitroglycerin Spray
  • Dexeryl (glycerol, Paraffin, Liquid, White Soft Paraffin)
  • Ginkor Fort (ginkgo Biloba, Heptaminol Hydrochloride, Troxerutin)
  • Morphine
  • Fixical (calcium Carbonate)
The patient was hospitalized. Although Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Coagulation Factor V Level Decreased, may still occur.
Aspegic Side Effect Report#7943279-1
Gastrointestinal Angiodysplasia, Rectal Haemorrhage
This Gastrointestinal Angiodysplasia problem was reported by a physician from France. A 79-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: ischaemic cardiomyopathy,atrial fibrillation. On
Oct 01, 2011 this consumer started treatment with Aspegic 325 (dosage: NA). The following drugs were being taken at the same time:
  • Pradaxa (220 Mg)
When using Aspegic 325, the patient experienced the following unwanted symptoms/side effects: Gastrointestinal Angiodysplasia, Rectal HaemorrhageThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Gastrointestinal Angiodysplasia, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#7761903-3
Cardiac Perforation, Cardiac Tamponade
This Cardiac Perforation side effect was reported by a physician from Switzerland. A male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Aspegic 325 (drug dosage: 500 Mg, Unk), which was initiated on
Apr 16, 2011. Concurrently used drugs:
  • Prasugrel Hydrochloride (60 Mg, Loading Dose)
  • Perlinganit (4 Mg/h)
.After starting to take Aspegic 325 the consumer reported adverse symptoms, such as: Cardiac Perforation, Cardiac TamponadeThese side effects may potentially be related to Aspegic 325. The patient was hospitalized.
Aspegic Side Effect Report#7735011-1
This is a report of a 71-year-old female patient (weight: NA) from Tunisia, suffering from the following health symptoms/conditions: NA, who was treated with Aspegic 325 (dosage: NA, start time:
Dec 25, 2010), combined with:
  • Plavix
  • Glucophage
  • Glyburide
  • Plavix
  • Captopril
  • Fenofibrate
and developed a serious reaction and side effect(s): after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in female patients, resulting in Sudden Death side effect.
Aspegic Side Effect Report#7690910-4
Coagulation Factor V Level Decreased, Prothrombin Level Decreased
This report suggests a potential Aspegic (acetylsalicylate Lysine) Coagulation Factor V Level Decreased side effect(s) that can have serious consequences. A 48-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Aspegic (acetylsalicylate Lysine) (dosage: NA) starting
Sep 11, 2009. After starting Aspegic (acetylsalicylate Lysine) the patient began experiencing various side effects, including: Coagulation Factor V Level Decreased, Prothrombin Level DecreasedAdditional drugs used concurrently:
  • Lovenox
  • Crestor
  • Isosorbide Dinitrate
  • Nicopatch (nicotine)
  • Atenolol
  • Plavix
  • Angiomax (1 Mg/kg, Bolus, Intravenous, 0.25 Mg/kg, Hr, Intravenous)
  • Angiomax (1 Mg/kg, Bolus, Intravenous, 0.25 Mg/kg, Hr, Intravenous)
Although Aspegic (acetylsalicylate Lysine) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Coagulation Factor V Level Decreased, may still occur.
Aspegic Side Effect Report#7630413-6
Convulsion, Fall, Inappropriate Antidiuretic Hormone Secretion, Haematoma
This Convulsion problem was reported by a physician from France. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Sep 16, 2000 this consumer started treatment with Aspegic 250 (dosage: NA). The following drugs were being taken at the same time:
  • Lasix
  • Lactulose
  • Paroxetine Hcl
  • Digoxin
  • Nitroderm
  • Levothyroxine Sodium
  • Haldol (5drop Per Day)
  • Acetaminophen W/ Propoxyphene Hcl
When using Aspegic 250, the patient experienced the following unwanted symptoms/side effects: Convulsion, Fall, Inappropriate Antidiuretic Hormone Secretion, HaematomaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Convulsion, may become evident only after a product is in use by the general population.
Aspegic Side Effect Report#7617965-7
Weight Decreased, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Diarrhoea, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Mixed Liver Injury, Dyspepsia
This Weight Decreased side effect was reported by a health professional from France. A male patient (weight:NA) experienced the following symptoms/conditions: myocardial ischaemia.The patient was prescribed Aspegic 325 (drug dosage: 100 Mg Per Day, Unk), which was initiated on
Dec 01, 2009. Concurrently used drugs:
  • Lanzor (30 Mg Per Day, Unk)
  • Diltiazem Hcl (60 Mg, Qid)
  • Corvasal (4 Mg, Qid)
  • Atorvastatin Calcium (20 Mg, Unk)
  • Atorvastatin Calcium (80 Mg, Unk)
  • Amlodipine (Unk Ukn, Unk)
  • Ikorel (10 Mg Per Day, Unk)
  • Rasilez (300 Mg, Qd)
.After starting to take Aspegic 325 the consumer reported adverse symptoms, such as: Weight Decreased, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Diarrhoea, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Mixed Liver Injury, DyspepsiaThese side effects may potentially be related to Aspegic 325. The patient was hospitalized.
Aspegic Side Effect Report#7612066-6
Aggression, Suicidal Ideation, Irritability, Depression
This is a report of a male patient (weight: NA) from France, suffering from the following health symptoms/conditions: systemic lupus erythematosus,epilepsy, who was treated with Aspegic 325 (dosage: NA, start time:
Jan 01, 2010), combined with:
  • Keppra
  • Trileptal
  • Plaquenil
and developed a serious reaction and side effect(s): Aggression, Suicidal Ideation, Irritability, Depression after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in male patients, resulting in Aggression side effect.


1 of 3 


The appearance of Aspegic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Aspegic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Aspegic Side Effects

    Did You Have a Aspegic Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Aspegic for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Aspegic Safety Alerts, Active Ingredients, Usage Information

    More About Aspegic

    Side Effects reported to FDA: 51

    Aspegic safety alerts: No

    Reported deaths: 5

    Reported hospitalizations: 16

    Latest Aspegic clinical trials